<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01934699</url>
  </required_header>
  <id_info>
    <org_study_id>10-004</org_study_id>
    <secondary_id>00012377</secondary_id>
    <nct_id>NCT01934699</nct_id>
  </id_info>
  <brief_title>Intraprocedural Determination of Myocardial Vitality Using 2 Different Imaging Methods</brief_title>
  <official_title>Intraprocedural Determination of Myocardial Vitality Using Speckle Tracking Echocardiography Compared to Two-time MRI Diagnostics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will compare myocard vitality diagnostics using 2D-Strain echography and&#xD;
      MRI.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each patient with typical angina pectoris symptoms will get echocardiographic examination&#xD;
      during the inclusion phase. If motion disorder of regional left ventricular myocardial wall&#xD;
      is detected, patient will get coronary angiography (not study related, caused of typical&#xD;
      angina pectoris symptoms and high probability of CHD). If coronary stenosis related to motion&#xD;
      disorder is available, patient will be randomized in two groups during coronary angiography.&#xD;
&#xD;
        -  First Group: Patient will get echocardiographic examination during coronary angiography.&#xD;
           2D-Strain Analysis will be performed based on data of this echocardiographic&#xD;
           examination. Only when vitality in the contraction impaired segments will be established&#xD;
           based on 2D-Strain Analysis, PCI (Percutaneous Coronary Intervention) will be performed.&#xD;
&#xD;
        -  Second Group: Coronary angiography by patient will be canceled. Patients will get&#xD;
           viability assessment using MRI(Magnetic resonance imaging) within the next 7 days. When&#xD;
           vitality will be established with MRI, patient will get PCI (Percutaneous Coronary&#xD;
           Intervention).&#xD;
&#xD;
      In addition, as part of a feasibility analysis, the possibility of a consolidation of data of&#xD;
      coronary angiography with the ultrasound images will be researched by first group of&#xD;
      patients. The aim is to simplify the visualization of the intraprocedural vitality detection.&#xD;
      For this purpose, a position sensor based on electromagnetic fields (EMT) will be used during&#xD;
      coronary angiography.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>State of health score</measure>
    <time_frame>6 month after diagnistics</time_frame>
    <description>State of health score will be determinated by all patients for the evaluation of clinical outcomes (using the standardized questionnaire on state of health (SF-36))6 months after clinical diagnostics.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricular function (ejection function)</measure>
    <time_frame>6 month after diagnistics</time_frame>
    <description>Left ventricular function (ejection function) by all patients will be determinated 6 month after diagnostics.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End-diastolic and end-systolic volume.</measure>
    <time_frame>6 month after diagnostics</time_frame>
    <description>End-diastolic and end-systolic volume will be determined by all patients 6 month after diagnostics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Capture of Major Adverse Cardiac and Cerebrovascular Events(MACCE)</measure>
    <time_frame>18 month after diagnostics</time_frame>
    <description>It will be determined, whether all patients suffered any major adverse cardiac and cerebrovascular events (MACCE) inter alia stroke, myocardial infarction, death 18 month after diagnostics</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Angina Pectoris</condition>
  <condition>Left Ventricular Wall Motion Abnormalities</condition>
  <arm_group>
    <arm_group_label>MRI-Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Myocardial vitality determination based on MRI diagnostics.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Echo-Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Myocardial vitality determination using echocardiography in combination with 2D-Strain Analysis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac ultrasound</intervention_name>
    <description>Patient will get echocardiographic examination during coronary angiography. 2D-Strain Analysis will be performed based on data of these echocardiographic examination. Only when vitality in the contraction impaired segments will be established based on 2D-Strain Analysis, PCI will be performed.</description>
    <arm_group_label>Echo-Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI scanner</intervention_name>
    <description>Coronary angiography on patient will be canceled. Patients will get viability assessment using MRI within the next 7 days. When vitality will be established with MRI, patient will get PCI.</description>
    <arm_group_label>MRI-Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Typical angina pectoris symptoms&#xD;
&#xD;
          -  Echocardiographic determination of regional motion disfunction of left ventricular&#xD;
             wall&#xD;
&#xD;
          -  Establishment of needly treatment of stenosis related to motion disorder based on&#xD;
             coronar angiography.&#xD;
&#xD;
          -  Feasibility of MRI-Examination.&#xD;
&#xD;
          -  Patients which are legally competent and which are mentally able to understand the&#xD;
             study staff&#xD;
&#xD;
          -  Patients give their written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy against contrast agent&#xD;
&#xD;
          -  Patients with limited renal function(GFR &lt; 60 ml/min)&#xD;
&#xD;
          -  Acute or instable angina pectoris&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Becker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Aachen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <state>NRW</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <study_first_submitted>August 29, 2013</study_first_submitted>
  <study_first_submitted_qc>August 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2013</study_first_posted>
  <last_update_submitted>September 22, 2015</last_update_submitted>
  <last_update_submitted_qc>September 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary stenosis</keyword>
  <keyword>Angina pectoris</keyword>
  <keyword>Left ventricular wall motion abnormalities</keyword>
  <keyword>2D-Strain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

